159 related articles for article (PubMed ID: 11870169)
1. T-cell/histiocyte-rich large B-cell lymphoma: a distinct clinicopathologic entity.
Achten R; Verhoef G; Vanuytsel L; De Wolf-Peeters C
J Clin Oncol; 2002 Mar; 20(5):1269-77. PubMed ID: 11870169
[TBL] [Abstract][Full Text] [Related]
2. Histiocyte-rich, T-cell-rich B-cell lymphoma: a distinct diffuse large B-cell lymphoma subtype showing characteristic morphologic and immunophenotypic features.
Achten R; Verhoef G; Vanuytsel L; De Wolf-Peeters C
Histopathology; 2002 Jan; 40(1):31-45. PubMed ID: 11903596
[TBL] [Abstract][Full Text] [Related]
3. Among diffuse large B-cell lymphomas, T-cell-rich/histiocyte-rich BCL and CD30+ anaplastic B-cell subtypes exhibit distinct clinical features.
Maes B; Anastasopoulou A; Kluin-Nelemans JC; Teodorovic I; Achten R; Carbone A; De Wolf-Peeters C;
Ann Oncol; 2001 Jun; 12(6):853-8. PubMed ID: 11484964
[TBL] [Abstract][Full Text] [Related]
4. T-cell/histiocyte-rich large B-cell lymphoma is a disseminated aggressive neoplasm: differential diagnosis from Hodgkin's lymphoma.
Fraga M; Sánchez-Verde L; Forteza J; García-Rivero A; Piris MA
Histopathology; 2002 Sep; 41(3):216-29. PubMed ID: 12207783
[TBL] [Abstract][Full Text] [Related]
5. T-cell/histiocyte-rich large B-cell lymphomas and classical diffuse large B-cell lymphomas have similar outcome after chemotherapy: a matched-control analysis.
Bouabdallah R; Mounier N; Guettier C; Molina T; Ribrag V; Thieblemont C; Sonet A; Delmer A; Belhadj K; Gaulard P; Gisselbrecht C; Xerri L
J Clin Oncol; 2003 Apr; 21(7):1271-7. PubMed ID: 12663714
[TBL] [Abstract][Full Text] [Related]
6. T cell/histiocyte-rich large B-cell lymphoma: an update on its biology and classification.
Tousseyn T; De Wolf-Peeters C
Virchows Arch; 2011 Dec; 459(6):557-63. PubMed ID: 22081105
[TBL] [Abstract][Full Text] [Related]
7. CD5+ T-cell/histiocyte-rich large B-cell lymphoma.
Chang CC; Bunyi-Teopengco E; Eshoa C; Chitambar CR; Kampalath B
Mod Pathol; 2002 Oct; 15(10):1051-7. PubMed ID: 12379751
[TBL] [Abstract][Full Text] [Related]
8. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
9. T-cell/histiocyte-rich large B-cell lymphoma displays a heterogeneity similar to diffuse large B-cell lymphoma: a clinicopathologic, immunohistochemical, and molecular study of 30 cases.
Wang J; Sun NC; Chen YY; Weiss LM
Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):109-15. PubMed ID: 15894921
[TBL] [Abstract][Full Text] [Related]
10. T-cell/histiocyte-rich large B-cell lymphoma in pediatric patients: an under-recognized entity?
Gheorghe G; Rangarajan HG; Camitta B; Segura A; Kroft S; Southern JF
Ann Clin Lab Sci; 2015; 45(1):73-8. PubMed ID: 25696014
[TBL] [Abstract][Full Text] [Related]
11. 'T-cell-rich large B-cell lymphoma'-'histiocyte-rich, T-cell-rich large B-cell lymphoma'-'T-cell/histiocyte-rich large B-cell lymphoma': will we ever see the wood for the trees?
De Wolf-Peeters C; Achten R
Histopathology; 2002 Sep; 41(3):269-71. PubMed ID: 12207791
[No Abstract] [Full Text] [Related]
12. Matched-pair analysis comparing the outcomes of T cell/histiocyte-rich large B cell lymphoma and diffuse large B cell lymphoma in patients treated with rituximab-CHOP.
Kim YS; Ji JH; Ko YH; Kim SJ; Kim WS
Acta Haematol; 2014; 131(3):156-61. PubMed ID: 24192382
[TBL] [Abstract][Full Text] [Related]
13. Micronodular T-cell/histiocyte-rich large B-cell lymphoma of the spleen: histology, immunophenotype, and differential diagnosis.
Dogan A; Burke JS; Goteri G; Stitson RN; Wotherspoon AC; Isaacson PG
Am J Surg Pathol; 2003 Jul; 27(7):903-11. PubMed ID: 12826882
[TBL] [Abstract][Full Text] [Related]
14. T-cell/histiocyte-rich large B-cell lymphoma shows transcriptional features suggestive of a tolerogenic host immune response.
Van Loo P; Tousseyn T; Vanhentenrijk V; Dierickx D; Malecka A; Vanden Bempt I; Verhoef G; Delabie J; Marynen P; Matthys P; De Wolf-Peeters C
Haematologica; 2010 Mar; 95(3):440-8. PubMed ID: 19797726
[TBL] [Abstract][Full Text] [Related]
15. T-cell/histiocyte-rich large B-cell lymphoma associated with a near-tetraploid karyotype and complex genetic abnormalities.
de Leval L; Harris NL; Lampertz S; Herens C
APMIS; 2006 Jun; 114(6):474-8. PubMed ID: 16856972
[TBL] [Abstract][Full Text] [Related]
16. Fatal necrotizing angiotropic Epstein-Barr virus-negative large B-cell lymphoma: a case report with unusual clinicopathological features in-between lymphomatoid granulomatosis and T-cell/histiocyte-rich large B-cell lymphoma.
Olivieri A; Sabattini E; Goteri G; Trappolini S; Saraceni F; Samorì A; Gini G; Leoni P; Olivieri J; Pileri SA
Medicine (Baltimore); 2014 Dec; 93(29):e353. PubMed ID: 25546693
[TBL] [Abstract][Full Text] [Related]
17. [T cell/histiocyte-rich large B cell lymphoma].
Liu DG; Du J; Yu Q
Zhonghua Bing Li Xue Za Zhi; 2005 Jun; 34(6):377-8. PubMed ID: 16185515
[No Abstract] [Full Text] [Related]
18. Large cleaved and immunoblastic lymphoma may represent two distinct clinicopathologic entities within the group of diffuse large B-cell lymphomas.
De Paepe P; Achten R; Verhoef G; Wlodarska I; Stul M; Vanhentenrijk V; Praet M; De Wolf-Peeters C
J Clin Oncol; 2005 Oct; 23(28):7060-8. PubMed ID: 16129841
[TBL] [Abstract][Full Text] [Related]
19. Immunophenotypic Characterization and Purification of Neoplastic Cells from Lymph Nodes Involved by T-Cell/Histiocyte-rich Large B-cell Lymphoma by Flow Cytometry and Flow Cytometric Cell Sorting.
Glynn E; Fromm JR
Cytometry B Clin Cytom; 2020 Jan; 98(1):88-98. PubMed ID: 31254446
[TBL] [Abstract][Full Text] [Related]
20. Centroblastic and centroblastic/centrocytic lymphoma associated with a prominent epithelioid granulomatous response: a clinicopathologic study of 50 cases.
Kojima M; Nakamura S; Ichimura K; Suzuki R; Kagami Y; Kondo E; Motoori T; Hosomura Y; Oyama T; Itoh H; Ban S; Yoshida K; Ohno Y; Shimizu K; Masawa N; Sugihara S
Mod Pathol; 2002 Jul; 15(7):750-8. PubMed ID: 12118113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]